Holen Sie sich die Stockscreener-App
13.25
0.76%
0.10
Kura Oncology Inc Aktie (KURA) Neueste Nachrichten
Kura Oncology (KURA) Chief Legal Officer Teresa Bair Sells 31,48 - GuruFocus
Kura Oncology (NASDAQ:KURA) Insider Sells 31,487 Shares - MarketBeat
Kura Oncology (NASDAQ: KURA) affiliate flags 4,345-share Rule 144 sale - Stock Titan
Kura Oncology (KURA) counsel offloads shares via 10b5-1 plan - Stock Titan
Great Lakes Advisors LLC Invests $2.85 Million in Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology (KURA) Q2 2026 Earnings Call Transcript - The Globe and Mail
Kura Oncology (NASDAQ: KURA) exec plans to sell 31,487 shares - Stock Titan
Kura Oncology (KURA) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Kura Oncology (NASDAQ:KURA) Gains Traction With Its AML Menin Inhibitor - Kalkine Media
Troy Wilson Bought 12% More Shares In Kura Oncology - simplywall.st
Teleconferência de Resultados do 2º Trimestre de 2026 da Kura Oncology (KURA): Vendas do KOMZIFTI Atingem US$ 9,1 Milhões - TradingKey
Kura Oncology (NASDAQ:KURA) Hits New 52-Week High Following Insider Buying Activity - MarketBeat
Kura Oncology stock hits 52-week high at 12.49 USD - Investing.com
Does Kura Oncology (KURA) Have the Potential to Rally 178.55% as Wall Street Analysts Expect? - Yahoo Finance
Why Kura Oncology (KURA) Is Up 14.5% After New Ziftomenib Resistance Data And Q2 Results - Yahoo Finance
Kura Oncology stock rises on CEO insider purchase By Investing.com - Investing.com South Africa
Why Is KURA Stock Rallying 8% After-Hours? - TradingView
Kura Oncology stock rises on CEO insider purchase - Investing.com
Kura Oncology CEO Troy Wilson Acquires 100,000 Shares at $11.12 Each - Kalkine Media
Troy Edward Wilson Purchases 100,000 Shares of Kura Oncology (NASDAQ:KURA) Stock - MarketBeat
Kura Oncology (NASDAQ: KURA) CEO buys more in 100,000-share insider trade - Stock Titan
Kura Oncology Inc (KURA) (Q2 2026) Earnings Call Highlights: KOM - GuruFocus
Kura Oncology Q3 EPS Increased by Brookline Capital Markets - MarketBeat
Q3 EPS Estimates for Kura Oncology Boosted by HC Wainwright - MarketBeat
Kura Oncology (KURA) investors report up to 9.7% beneficial ownership stakes - Stock Titan
Kura Oncology (NASDAQ:KURA) Stock Price Up 8% on Analyst Upgrade - MarketBeat
A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $23 to $40 - Moomoo
Kura Oncology Q2 2026 Earnings Call Highlights Precision Oncology StrategyPretax Income Report - vinanet.vn
Kura Oncology FY2029 EPS Cut by Brookline Capital Markets - MarketBeat
Kura Oncology (KURA) Receives a Buy from Bank of America Securities - The Globe and Mail
Kura Oncology (KURA) Q2 2026 Earnings Call: KOMZIFTI-Umsatz erreicht 9,1 Mio. USD - TradingKey
Lake Street Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $23 - Moomoo
BofA Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $31 - Moomoo
Kura Oncology, Inc. Stock 12‑Month Price Target Raised to $32, Implies 222% Upside - TradingView
Kura Oncology (NASDAQ:KURA) Shares Gap Up After Strong Earnings - MarketBeat
KURA Maintained by Wedbush -- Price Target Raised to $38 - GuruFocus
Kura Oncology (NASDAQ:KURA) Price Target Raised to $38.00 at Wedbush - MarketBeat
Wedbush Adjusts Price Target on Kura Oncology to $38 From $36, Keeps Outperform Rating - marketscreener.com
Kura Oncology (NASDAQ:KURA): What Does the Latest Update Mean for Clinical Evidence? - Kalkine Media
Kura Oncology, Inc. Stock 12‑Month Price Target Raised to $31.83, Implies 220% Upside - tradingview.com
Kura Oncology (KURA) Q2 2026 Results Highlight Valuation Challen - GuruFocus
Kura Oncology Q2 2026 Earnings Call Transcript - MarketBeat
Kura Oncology, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Kura Oncology Q2 EPS $(0.77) beats estimate, sales miss - scanx.trade
Kura Oncology Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Kura Oncology tops Q2 2026 estimates as launch gains - Investing.com
Kura Oncology (NASDAQ:KURA) Issues Earnings Results - MarketBeat
Kura Oncology (KURA) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Kura Oncology, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Kura Oncology Inc (KURA) Reports Q2 Revenue of $20.9M with Net L - GuruFocus
Kura Oncology Q2 Diluted Loss Widens, Revenue Rises - marketscreener.com
Kura Oncology: Q2 Earnings Snapshot - marketscreener.com
Earnings Flash (KURA) Kura Oncology Posts Q2 Loss Per Share $0.77, vs. FactSet Est of Loss $0.88 - marketscreener.com
KURA ONCOLOGY ($KURA) Releases Q2 2026 Earnings - Quiver Quantitative
Q2 2026 Kura Oncology, Inc. Earnings Call Transcript - GuruFocus
Kura Oncology (KURA) grows revenue to $39.1M but widens net loss - Stock Titan
Kura Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Kura Oncology Q2 product revenue rises 57% on KOMZIFTI uptake - TradingView
Kura Oncology Reports Second Quarter 2026 Financial Results - The Manila Times
Earnings Flash (KURA) Kura Oncology, Inc. Reports Q2 Revenue $20.9M, vs. FactSet Est of $20.2M - marketscreener.com
BRIEF-Kura Oncology Q2 Operating Expenses USD 93.884 Million - TradingView
Kura Oncology, Inc. expected to post a loss of 88 cents a shareEarnings Preview - TradingView
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):